These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29445153)

  • 21. A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission.
    Xie X; Kum DB; Xia H; Luo H; Shan C; Zou J; Muruato AE; Medeiros DBA; Nunes BTD; Dallmeier K; Rossi SL; Weaver SC; Neyts J; Wang T; Vasconcelos PFC; Shi PY
    Cell Host Microbe; 2018 Oct; 24(4):487-499.e5. PubMed ID: 30308155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates.
    Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; Huang YS; Vanlandingham DL; Horton JS; Clements DE; Lehrer AT
    Front Immunol; 2018; 9():2464. PubMed ID: 30467501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
    Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.
    Garcia G; Chakravarty N; Abu AE; Jeyachandran AV; Takano KA; Brown R; Morizono K; Arumugaswami V
    Microbiol Spectr; 2022 Oct; 10(5):e0113722. PubMed ID: 36169338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice.
    Han JF; Qiu Y; Yu JY; Wang HJ; Deng YQ; Li XF; Zhao H; Sun HX; Qin CF
    Sci Rep; 2017 Aug; 7(1):10047. PubMed ID: 28855646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone.
    Touret F; Gilles M; Klitting R; Aubry F; de Lamballerie X; Nougairède A
    Emerg Microbes Infect; 2018 Sep; 7(1):161. PubMed ID: 30254297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
    Chattopadhyay A; Aguilar PV; Bopp NE; Yarovinsky TO; Weaver SC; Rose JK
    Vaccine; 2018 Jun; 36(27):3894-3900. PubMed ID: 29807712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal vaccination and protective immunity against Zika virus vertical transmission.
    Shan C; Xie X; Luo H; Muruato AE; Liu Y; Wakamiya M; La JH; Chung JM; Weaver SC; Wang T; Shi PY
    Nat Commun; 2019 Dec; 10(1):5677. PubMed ID: 31831806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a Species E Adenovirus Vector as a Zika virus vaccine.
    Bullard BL; Corder BN; Gordon DN; Pierson TC; Weaver EA
    Sci Rep; 2020 Feb; 10(1):3613. PubMed ID: 32107394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic stability of live-attenuated Zika vaccine candidates.
    Muruato AE; Shan C; Fontes-Garfias CR; Liu Y; Cao Z; Gao Q; Weaver SC; Shi PY
    Antiviral Res; 2019 Nov; 171():104596. PubMed ID: 31493417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models.
    Shan C; Muruato AE; Nunes BTD; Luo H; Xie X; Medeiros DBA; Wakamiya M; Tesh RB; Barrett AD; Wang T; Weaver SC; Vasconcelos PFC; Rossi SL; Shi PY
    Nat Med; 2017 Jun; 23(6):763-767. PubMed ID: 28394328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
    Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
    Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
    Richner JM; Jagger BW; Shan C; Fontes CR; Dowd KA; Cao B; Himansu S; Caine EA; Nunes BTD; Medeiros DBA; Muruato AE; Foreman BM; Luo H; Wang T; Barrett AD; Weaver SC; Vasconcelos PFC; Rossi SL; Ciaramella G; Mysorekar IU; Pierson TC; Shi PY; Diamond MS
    Cell; 2017 Jul; 170(2):273-283.e12. PubMed ID: 28708997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Sides of a Coin: a Zika Virus Mutation Selected in Pregnant Rhesus Macaques Promotes Fetal Infection in Mice but at a Cost of Reduced Fitness in Nonpregnant Macaques and Diminished Transmissibility by Vectors.
    Lemos D; Stuart JB; Louie W; Singapuri A; Ramírez AL; Watanabe J; Usachenko J; Keesler RI; Sanchez-San Martin C; Li T; Martyn C; Oliveira G; Saraf S; Grubaugh ND; Andersen KG; Thissen J; Allen J; Borucki M; Tsetsarkin KA; Pletnev AG; Chiu CY; Van Rompay KKA; Coffey LL
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
    Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J
    Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.
    López-Camacho C; Abbink P; Larocca RA; Dejnirattisai W; Boyd M; Badamchi-Zadeh A; Wallace ZR; Doig J; Velazquez RS; Neto RDL; Coelho DF; Kim YC; Donald CL; Owsianka A; De Lorenzo G; Kohl A; Gilbert SC; Dorrell L; Mongkolsapaya J; Patel AH; Screaton GR; Barouch DH; Hill AVS; Reyes-Sandoval A
    Nat Commun; 2018 Jun; 9(1):2441. PubMed ID: 29934593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.